David Jin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Jin
David Jin is recorded as CFO at Fortress Biotech, Inc. (FBIO). Fortress Biotech, Inc. reported in an 8-K filed July 22, 2022 that David Jin was appointed Chief Financial Officer, effective August 16, 2022.
“In connection with such resignation, effective August 16, 2022, David Jin, 32, who has served as the Company's Vice President of Corporate Development and the Interim Principal Executive Officer and Chief Operating Officer of the Company's subsidiary Avenue Therapeutics, Inc. ("Avenue"), was appointed Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-08-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Fortress Biotech, Inc.
Other people whose current roles at this company are on record from its filings.
- Lindsay A. Rosenwald CEO, Board Member
- Michael S. Weiss Chairman, Board Member
- Robyn M. Hunter CFO
- Dov Klein Board Member
- Dov Klein, C.P.A. Board Member
- Eric K. Rowinsky Board Member
- Eric R. Rowinsky, M.D. Board Member
- J. Jay Lobell Board Member
- Jimmie Harvey Board Member
- Jimmie Harvey, Jr. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.